Aimovig: Expiry of patents related to CGRP receptor antibodies in EU on December 18, 2029 and in US on May 17, 2032 (Amgen) - Feb 17, 2024 - Annual Report 2023: Expiry of patents related to methods of treatment in EU on August 10, 2035 and US on April 22, 2036; SPC in France, Italy and Spain and UK until 2033, Expiry of patents related to compositions and pharmaceutical formulations in US on Apr 1, 2039
Patent • CNS Disorders • Migraine • Pain
|